发明授权
US08496962B2 Trans-adjuvant system 有权
跨佐剂系统

Trans-adjuvant system
摘要:
The present invention relates to a novel adjuvant system that generates an efficient immune response against antigens of various origins while reducing the risk of toxic side effects attendant to the use of known adjuvants. The novel adjuvant of the present invention comprises virosomes and allows antigenic molecules to be bound to or encapsulated in a variety of delivery vehicles which are easier to prepare for virosomes.
公开/授权文献
信息查询
0/0